Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Logan

Concepts (80)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiotherapy, Intensity-Modulated
1
2019
143
0.530
Why?
Receptor Protein-Tyrosine Kinases
5
2016
227
0.490
Why?
Bone Neoplasms
1
2019
272
0.470
Why?
Carcinoma, Non-Small-Cell Lung
7
2016
1195
0.410
Why?
Randomized Controlled Trials as Topic
2
2019
1763
0.400
Why?
Patient Selection
2
2020
728
0.390
Why?
Rectal Neoplasms
1
2013
160
0.360
Why?
Lung Neoplasms
7
2016
2675
0.300
Why?
Protein Kinase Inhibitors
5
2016
983
0.300
Why?
Patient Acceptance of Health Care
1
2016
881
0.300
Why?
Drug Resistance, Neoplasm
3
2016
893
0.230
Why?
Lactams, Macrocyclic
2
2016
51
0.230
Why?
Carbazoles
2
2015
53
0.220
Why?
Practice Patterns, Physicians'
1
2013
1408
0.210
Why?
Piperidines
2
2015
225
0.200
Why?
Psychiatric Status Rating Scales
2
2020
522
0.160
Why?
Neoplasms
1
2016
2954
0.160
Why?
Pharmacogenomic Testing
1
2020
63
0.150
Why?
Pharmacogenetics
1
2019
176
0.140
Why?
Antidepressive Agents
1
2020
235
0.130
Why?
Pyrimidines
3
2016
532
0.130
Why?
Ipilimumab
1
2017
44
0.130
Why?
Brain Neoplasms
2
2017
1325
0.130
Why?
Aged, 80 and over
3
2019
8391
0.120
Why?
Eligibility Determination
1
2016
73
0.120
Why?
Aged
7
2020
26432
0.120
Why?
Age Distribution
1
2016
399
0.110
Why?
Sex Distribution
1
2016
382
0.110
Why?
Scleroderma, Localized
1
2015
11
0.110
Why?
Informed Consent
1
2016
195
0.110
Why?
Pemetrexed
1
2015
40
0.110
Why?
Pyrazoles
2
2016
517
0.110
Why?
Acrylamides
1
2015
74
0.110
Why?
Meningeal Carcinomatosis
1
2013
7
0.100
Why?
Meningeal Neoplasms
1
2015
95
0.100
Why?
Spinal Neoplasms
1
2013
36
0.100
Why?
Antineoplastic Agents
2
2015
2219
0.100
Why?
Prognosis
3
2016
4351
0.090
Why?
Gene Rearrangement
1
2013
156
0.090
Why?
Neoplasm Staging
2
2013
1488
0.090
Why?
SEER Program
1
2013
233
0.090
Why?
Lymphatic Metastasis
1
2013
335
0.090
Why?
Treatment Outcome
3
2019
11821
0.090
Why?
ErbB Receptors
1
2015
636
0.090
Why?
Pyridines
1
2015
610
0.080
Why?
Male
10
2020
73396
0.080
Why?
Kaplan-Meier Estimate
1
2013
970
0.080
Why?
Middle Aged
8
2017
36619
0.080
Why?
Melanoma
1
2017
765
0.080
Why?
Mutation
3
2016
4093
0.080
Why?
Prevalence
1
2016
2861
0.070
Why?
Survival Rate
1
2013
2092
0.070
Why?
Cohort Studies
1
2019
6077
0.070
Why?
Humans
13
2020
146342
0.070
Why?
Adult
6
2017
41087
0.060
Why?
United States
2
2016
16136
0.060
Why?
Female
9
2020
79499
0.060
Why?
Lactams
2
2016
28
0.060
Why?
Sulfones
2
2016
127
0.060
Why?
Aminopyridines
2
2016
128
0.060
Why?
Drug Substitution
1
2020
62
0.040
Why?
Treatment Failure
1
2020
361
0.040
Why?
Cell Line, Tumor
2
2016
3545
0.030
Why?
CTLA-4 Antigen
1
2017
105
0.030
Why?
Liver Failure
1
2015
79
0.030
Why?
Dermatitis
1
2015
20
0.030
Why?
Antineoplastic Agents, Immunological
1
2017
200
0.030
Why?
Double-Blind Method
1
2019
2070
0.030
Why?
Molecular Structure
1
2015
484
0.030
Why?
Radiosurgery
1
2017
398
0.020
Why?
Cell Survival
1
2016
1105
0.020
Why?
Binding Sites
1
2015
1309
0.020
Why?
Hyperglycemia
1
2015
384
0.020
Why?
Dose-Response Relationship, Drug
1
2015
2022
0.020
Why?
Liver Neoplasms
1
2015
776
0.020
Why?
Cell Proliferation
1
2016
2502
0.020
Why?
Neoplasm Recurrence, Local
1
2015
1160
0.020
Why?
Young Adult
1
2017
14330
0.010
Why?
Retrospective Studies
1
2017
17438
0.010
Why?
Adolescent
1
2017
22557
0.010
Why?
Logan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)